Boston Scientific (BSX) Share-based Compensation (2009 - 2026)
Boston Scientific (BSX) posted quarterly Share-based Compensation of $87.0 million for Q2 2026, up 16.0% year-over-year from $75.0 million in Q2 2025, and up 4.82% on a QoQ basis from $83.0 million in Q1 2026.
Boston Scientific (BSX) Share-based Compensation (2009 - 2026) Analysis & Trends
Boston Scientific has reported Share-based Compensation for 18 years, with the latest figure at $87.0 million in Q2 2026.
- Share-based Compensation for Q2 2026 came in at $87.0 million, up 16.0% year-over-year; the trailing twelve-month figure through Jun 2026 was $320.0 million (up 11.89% YoY), and the FY2025 annual result was $299.0 million, up 12.41% from the prior year.
- Share-based Compensation grew to $87.0 million in Q2 2026, from $83.0 million in the prior quarter.
- Over five years, Share-based Compensation peaked at $87.0 million in Q2 2026 and troughed at $52.0 million in Q1 2022.
- A 5-year average of $66.0 million and a median of $64.5 million in 2024 frame the typical range for Share-based Compensation.
- The widest annual swing landed in 2023, when Share-based Compensation gained 1.72%; it then increased 17.46% in 2025.
- A 5-year view of Share-based Compensation shows it stood at $55.0 million in 2022, then increased by 7.27% to $59.0 million in 2023, then climbed by 16.95% to $69.0 million in 2024, then gained by 2.9% to $71.0 million in 2025, then rose by 22.54% to $87.0 million in 2026.
- Per Business Quant data, the three most recent Share-based Compensation figures were $87.0 million in Q2 2026, $83.0 million in Q1 2026, and $71.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Stryker | 129.71 Bn | 126.23 Bn | 4.50 Bn | 7.00 Mn |
| 3 | Medtronic | 120.07 Bn | 110.85 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn | 87.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 42.20 Mn |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn | 39.00 Mn |
| 7 | GE HealthCare Technologies | 34.03 Bn | 31.92 Bn | 2.18 Bn | 45.00 Mn |
| 8 | Koninklijke Philips | 26.51 Bn | 23.19 Bn | 4.55 Bn | 94.15 Mn |
| 9 | Steris | 23.20 Bn | 22.72 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Zimmer Biomet Holdings | 19.37 Bn | 18.96 Bn | 1.54 Bn | 23.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 87.00 Mn |
| Jun 30, 2026 | 87.00 Mn |
| Mar 31, 2026 | 83.00 Mn |
| Mar 31, 2026 | 83.00 Mn |
| Dec 31, 2025 | 71.00 Mn |
| Dec 31, 2025 | 71.00 Mn |
| Sep 30, 2025 | 79.00 Mn |
| Sep 30, 2025 | 79.00 Mn |
| Jun 30, 2025 | 75.00 Mn |
| Jun 30, 2025 | 75.00 Mn |
| Mar 31, 2025 | 74.00 Mn |
| Mar 31, 2025 | 74.00 Mn |
| Dec 31, 2024 | 69.00 Mn |
| Dec 31, 2024 | 69.00 Mn |
| Sep 30, 2024 | 68.00 Mn |
| Sep 30, 2024 | 68.00 Mn |
| Jun 30, 2024 | 66.00 Mn |
| Jun 30, 2024 | 66.00 Mn |
| Mar 31, 2024 | 63.00 Mn |
| Mar 31, 2024 | 63.00 Mn |